Similar companies
Income Statement (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Gross Profit | -6.8M | 3.9% |
| Cost of Revenue | 6.8M | 3.9% |
| Operating expense | 34M | 12.5% |
| Net Income | -33M | 12% |
| EBITDA | -34M | 11.6% |
Balance Sheet (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Total Assets | 110M | 18.9% |
| Total Liabilities | 34M | 6.9% |
| Total Equity | 76M | 26.9% |
| Shares Outstanding | 36M | 0.1% |
Cash Flow (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Cash from operations | -25M | 22.7% |
| Cash from investing | -190,000 | 215.3% |
| Cash from financing | 69,000 | 93.6% |
EPS
Financial Highlights for Biomea Fusion in Q3 '24
Gross Profit stood at -6.8M, marking a 3.9% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 6.8M, a -3.9% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 34M, showing a -12.5% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -33M, showing a 12% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was -34M, showing a 11.6% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
The company's performance remained stable this quarter with no significant positive or negative changes in the key financial metrics.
